112 related articles for article (PubMed ID: 685891)
1. Effect of prednisone on growth and bone mineral content in childhood glomerular disease.
Chesney RW; Mazess RB; Rose P; Jax DK
Am J Dis Child; 1978 Aug; 132(8):768-72. PubMed ID: 685891
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral status measured by direct photon absorptiometry in childhood renal disease.
Chesney RW; Mazess RB; Rose PG; Jax DK
Pediatrics; 1977 Dec; 60(6):864-72. PubMed ID: 600598
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy.
Polito C; La Manna A; Todisco N; Cimmaruta E; Sessa G; Pirozzi M
Clin Pediatr (Phila); 1995 May; 34(5):234-6. PubMed ID: 7628164
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn's disease.
Issenman RM; Atkinson SA; Radoja C; Fraher L
J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):401-6. PubMed ID: 8145096
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
[TBL] [Abstract][Full Text] [Related]
6. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
Saggese G; Baroncelli GI; Bertelloni S; Perri G
J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
[TBL] [Abstract][Full Text] [Related]
7. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
Leonard MB; Feldman HI; Shults J; Zemel BS; Foster BJ; Stallings VA
N Engl J Med; 2004 Aug; 351(9):868-75. PubMed ID: 15329424
[TBL] [Abstract][Full Text] [Related]
8. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
Lai HC; FitzSimmons SC; Allen DB; Kosorok MR; Rosenstein BJ; Campbell PW; Farrell PM
N Engl J Med; 2000 Mar; 342(12):851-9. PubMed ID: 10727589
[TBL] [Abstract][Full Text] [Related]
9. Delayed pubertal growth spurt and normal adult height attainment in boys receiving long-term alternate-day prednisone therapy.
Polito C; La Manna A; Papale MR; Villani G
Clin Pediatr (Phila); 1999 May; 38(5):279-85. PubMed ID: 10349525
[TBL] [Abstract][Full Text] [Related]
10. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment.
Rickers H; Deding A; Christiansen C; Rødbro P
Calcif Tissue Int; 1984 May; 36(3):269-73. PubMed ID: 6432291
[TBL] [Abstract][Full Text] [Related]
11. Persistence of diminished bone mineral content following renal transplantation in childhood.
Chesney RW; Rose PG; Mazess RB
Pediatrics; 1984 Apr; 73(4):459-66. PubMed ID: 6369239
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
[TBL] [Abstract][Full Text] [Related]
13. Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation.
Broyer M; Guest G; Gagnadoux MF
J Pediatr; 1992 May; 120(5):721-5. PubMed ID: 1578306
[TBL] [Abstract][Full Text] [Related]
14. Effect of exogenous corticosteroid therapy on growth in children with HBsAg-negative chronic aggressive hepatitis.
Clark JH; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 1984; 3(1):72-6. PubMed ID: 6694051
[TBL] [Abstract][Full Text] [Related]
15. Growth of asthmatic children during treatment with alternate-day steriods.
Reimer LG; Morris HG; Ellis EF
J Allergy Clin Immunol; 1975 Apr; 55(4):224-31. PubMed ID: 1123495
[TBL] [Abstract][Full Text] [Related]
16. Growth following renal transplantation in children and adolescents.
Hoda Q; Hasinoff DJ; Arbus GS
Clin Nephrol; 1975 Jan; 3(1):6-9. PubMed ID: 165024
[TBL] [Abstract][Full Text] [Related]
17. Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.
Chesney RW; Mazess RB; Hamstra AJ; DeLuca HF; O'Reagan S
Lancet; 1978 Nov; 2(8100):1123-5. PubMed ID: 82684
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism.
Ahmed SF; Russell S; Rashid R; Beattie TJ; Murphy AV; Ramage IJ; Maxwell H
Pediatr Nephrol; 2005 Oct; 20(10):1466-72. PubMed ID: 16047218
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment.
Als OS; Christiansen C; Hellesen C
Clin Rheumatol; 1984 Jun; 3(2):201-8. PubMed ID: 6467862
[TBL] [Abstract][Full Text] [Related]
20. Alternate-day corticosteroid therapy in juvenile chronic polyarthritis.
Ansell BM; Bywaters EG
J Rheumatol; 1974 Jun; 1(2):176-86. PubMed ID: 4457641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
